NSE - Delayed Quote INR

Tatva Chintan Pharma Chem Limited (TATVA.NS)

Compare
914.95 -30.95 (-3.27%)
At close: October 25 at 3:30 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 1.05B
Earnings 52.09M
?

Analyst Price Targets

1,000.00
1,300.75 Average
914.95 Current
1,850.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
No. of Analysts 1--33
Avg. Estimate 5.6024.334.8
Low Estimate 5.6021.929.7
High Estimate 5.6025.838.2
Year Ago EPS 4.293.4313.2624.3

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
No. of Analysts 3--33
Avg. Estimate 1.03B--5.46B7.08B
Low Estimate 940M--5.19B6.21B
High Estimate 1.09B--5.77B7.85B
Year Ago Sales ----3.94B5.46B
Sales Growth (year/est) ----38.80%29.50%

Earnings History

CURRENCY IN USD 6/30/2023 9/30/2023 12/31/2023 3/31/2024
EPS Est. 3.75.275.24.15
EPS Actual 4.293.431.484.11
Difference 0.59-1.84-3.72-0.04
Surprise % 15.90%-34.90%-71.50%-1.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
Current Estimate 5.6024.334.8
7 Days Ago 5.6024.334.8
30 Days Ago 0032.2743.72
60 Days Ago 0032.2743.72
90 Days Ago 0036.853.27

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD TATVA.NSIndustrySectorS&P 500
Current Qtr. 30.50%----4.50%
Next Qtr. ------9.60%
Current Year 83.30%----2.10%
Next Year 43.20%----12.90%
Next 5 Years (per annum) 42.30%----11.76%
Past 5 Years (per annum) --------

Related Tickers